Relationship between advanced glycation end products and plaque progression in patients with acute coronary syndrome: the JAPAN-ACS sub-study.
about
Serum Levels of Toxic AGEs (TAGE) May Be a Promising Novel Biomarker for the Onset/Progression of Lifestyle-Related DiseasesSoluble Receptor for Advanced Glycation End Product: A Biomarker for Acute Coronary SyndromePharmacologic Approaches Against Advanced Glycation End Products (AGEs) in Diabetic Cardiovascular DiseaseAssessment of the concentrations of various advanced glycation end-products in beverages and foods that are commonly consumed in JapanEffect of Collagen Tripeptide on Atherosclerosis in Healthy HumansToxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALDHaemoglobin A1c even within non-diabetic level is a predictor of cardiovascular disease in a general Japanese population: the Hisayama Study.Effects of pitavastatin versus atorvastatin on the peripheral endothelial progenitor cells and vascular endothelial growth factor in high-risk patients: a pilot prospective, double-blind, randomized studyImmunization with advanced glycation end products modified low density lipoprotein inhibits atherosclerosis progression in diabetic apoE and LDLR null miceInvolvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategiesAssociation of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitusThe receptor for advanced glycation end products and risk of peripheral arterial disease, amputation or death in type 2 diabetes: a population-based cohort study.Association between blood glucose variability and coronary plaque instability in patients with acute coronary syndromes.Soluble RAGEs - Prospects for treating & tracking metabolic and inflammatory diseaseLong-term clinical outcome in patients with acute coronary syndrome and dysglycaemiaAnalysis of advanced glycation end products in the DHS Mind Study.CML/RAGE signal induces calcification cascade in diabetesDifferential association of visceral adipose tissue with coronary plaque characteristics in patients with and without diabetes mellitusDamaging effects of hyperglycemia on cardiovascular function: spotlight on glucose metabolic pathways.Protective role of sulphoraphane against vascular complications in diabetes.Cellular mechanisms and consequences of glycation in atherosclerosis and obesity.Advanced glycation end products potentiate citrated plasma-evoked oxidative and inflammatory reactions in endothelial cells by up-regulating protease-activated receptor-1 expression.Glycation and cardiovascular disease in diabetes: A perspective on the concept of metabolic memory.Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes.Ratio of serum levels of AGEs to soluble RAGE is correlated with trimethylamine-N-oxide in non-diabetic subjects.Soluble RAGE plasma levels in patients with coronary artery disease and peripheral artery disease.AGE/RAGE-Induced EMP Release via the NOX-Derived ROS Pathway.
P2860
Q26747425-44200EBB-5DB5-4F05-AABB-2B1AEA826727Q26780488-28411A8F-3B83-4245-A383-366B6C5FAD33Q26782422-2B1C2C94-4635-4AF7-8EEB-CBE3074F9DE9Q28543766-73C875D1-1093-4A3A-B69F-8A27477E4B5DQ33676014-B68016EF-2AB8-4596-8BC1-5A942C54A371Q33852213-553F64A2-17BB-4643-94E6-291CEFAD2165Q34252878-4FA30D00-45E4-40BB-A728-4980064F1D8DQ34467988-484DB63A-BC0C-4AF0-AC6D-48A20DBCE514Q34528035-7A9BA504-2B79-47EC-881E-8F5317553AACQ34728267-EA5455E0-143A-4316-BAE7-4B530ABF2960Q35610045-A2F5B06B-D92E-4BF6-95A6-85C95133CDE1Q35896110-58070E56-090C-4341-9E17-7B1983E3616EQ35986383-49A1DB91-CA3A-4BDB-AA4B-1228AA574095Q35991574-825457E1-5254-4B4D-B06F-A07E0D22CF68Q36070922-FA15DCAF-2418-4AD3-8A9A-201786FAC932Q36600193-B20ADA69-9ED8-445C-807B-14CAE734F26DQ37539750-54483B12-A362-4E72-A1C3-030442A1850FQ37683609-F5F9A563-F5C2-4ED7-A66F-4C663B1BFEECQ38620860-2FA74BA4-7091-4426-AD04-A91E55771069Q38721709-331A0E78-2B5A-4DC4-9776-091178D43323Q38831558-A92D03EE-1235-4320-9525-049FA5707558Q38895998-9A8D1217-1025-4406-97B9-958BB86E1684Q38936100-1EB59937-402C-40CD-BF9D-B6D14DB857B6Q42115221-37AAB6E2-5F4E-460B-A089-FE39AAD47D15Q48243790-0CD37C08-4D27-452B-A819-73D09B541DEEQ54605224-4FE4DC64-5887-457D-86DB-73F1B27A49E8Q55361805-E6FE7FE8-3E1C-4629-BF95-9161041C6A2A
P2860
Relationship between advanced glycation end products and plaque progression in patients with acute coronary syndrome: the JAPAN-ACS sub-study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Relationship between advanced ...... rome: the JAPAN-ACS sub-study.
@ast
Relationship between advanced ...... rome: the JAPAN-ACS sub-study.
@en
type
label
Relationship between advanced ...... rome: the JAPAN-ACS sub-study.
@ast
Relationship between advanced ...... rome: the JAPAN-ACS sub-study.
@en
prefLabel
Relationship between advanced ...... rome: the JAPAN-ACS sub-study.
@ast
Relationship between advanced ...... rome: the JAPAN-ACS sub-study.
@en
P2093
P2860
P356
P1476
Relationship between advanced ...... rome: the JAPAN-ACS sub-study.
@en
P2093
Hiroyuki Daida
JAPAN-ACS Investigators
Katsumi Miyauchi
Masakazu Yamagishi
Masayoshi Takeuchi
Masunori Matsuzaki
Sho-ichi Yamagishi
Takafumi Hiro
Takatoshi Kasai
Takeshi Kimura
P2860
P2888
P356
10.1186/1475-2840-12-5
P407
P577
2013-01-07T00:00:00Z
P5875
P6179
1038251780